Coumadin Expert Witnesses in Delaware

This highly qualified expert earned his BA from New York University and his MD from Jefferson Medical College. After completing his residency at Temple University Hospital, this expert went on to complete a fellowship in Hematology-Oncology at Fox-Chase Cancer Center. He is also active in his field as a member of numerous medical societies including the American Society of Clinical Oncology, Transfusion Committee, and the Society of Integrative Oncology. He has published 11 journal articles and 1 book. He lectures nationally on topics ranging from breast cancer, genomic/genetics, lifestyle intervention. Formerly he held roles at Elmhurt Hospital/Mount Sinai Medical Center, Abington Hematology/Oncology Associates, and Holy Redeemer Hospital and Medical Center. Currently he is an Assistant Professor at a university in New Jersey and a Medical Oncologist/Hematologist, Director of Practice Development, and Director of Integrative Oncology at the MD Anderson Cancer Center in New Jersey.

This highly-qualified expert is triple-board certified in internal medicine, medical oncology, and medical hematology. He received his BA in East Asian studies from Washington University at St. Louis before earning his MD from Albert Einstein College of Medicine. He completed both an internship and residency in internal medicine at Beth Deaconness Medical Center before completing a clinical fellowship in hematology and oncology at Icahn School of Medicine, where he spent one year as the chief fellow. This expert is active in his field as a member of the American Society of Clinical Oncology and the American Society of Hematology. He has formerly served as the chief quality officer of oncology, as well as an assistant professor of oncology, at Montefiore Medical Center. Currently, this expert serves as the quality officer of hematologic malignancies and an assistant professor of medical oncology at a medical school in Pennsylvania.

This qualified expert has nearly a decade of board-certified experience in his field. He earned his undergraduate degree in premedical education from the Adamjee Government Science College and his MD from the Dow Medical College in Pakistan. He then worked as an administrator, medical officer, and house staff general surgeon in the Civil Hospital of Karachi. He then completed a residency in internal medicine at the University of Texas Medical Branch, Galveston before going on to complete a prestigious fellowship in hematology and oncology from Albert Einstein College/Montefiore Medical Center. This expert is triple board certified in internal medicine, hematology, and medical oncology. He is very active in his field as a member of multiple professional societies including the Society for Immunotherapy of Cancer, the European Society for Medical Oncology, the American Association of Cancer Research, the American Society of Hematology, and the American Society of Clinical Oncology. In addition, this expert has published over 40 peer-reviewed articles. Formerly, this expert served as a physician in hematology and oncology at the Greater Washington Oncology Associates and was the director of clinical oncology at Medimmune/AstraZeneca. He also was a clinical instructor for internal medicine residents at Prince George Hospital. Currently, this expert is a clinical program lead for a biotechnology company and he is an independent practicing physician in hematology and oncology.

This highly qualified, triple board certified doctor completed his MD at Vanderbilt University Medical Center. He completed his residency at Vanderbilt University Medical Center and then went on to complete a fellowship in hematology and medical oncology at Memorial Sloan- Kettering Cancer Center. He is a member of the American Society of Clinical Oncology and the American Society of Hematology. He has published more than 120 publications. He is a former Associate Professor of Medicine at Weill Medical College of Cornell University and a former Associate Attending Physician at Sloan-Kettering Cancer Center. He recently retired from a major university where he was Professor of Medical Oncology and the inaugural Director of the Division of Hematological Malignancies and Hematopoietic Stem Cell Transplantation.